Results 41 to 50 of about 47,261 (313)
Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem? [PDF]
With over 15 FDA approved drugs on the market and numerous ongoing clinical trials, RNA therapeutics, such as small interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs), have shown great potential to treat human disease.
Dowdy SF.
europepmc +2 more sources
Probing Endosomal Escape Using pHlexi Nanoparticles [PDF]
The effective escape of nanocarriers from endosomal compartments of the cell remains a major hurdle in nanomedicine. The endosomal escape of pH‐responsive, self‐assembled, dual component particles based on poly[2‐(diethylamino)ethyl methacrylate)(PDEAEMA) and poly(ethylene glycol)‐b‐poly[2‐(diethylamino)ethyl methacrylate) (PEG‐b‐PDEAEMA) has been ...
Kongkatigumjorn, N +6 more
openaire +3 more sources
Munson et al. develop a high-throughput Galectin-9 reporter based endosomal escape imaging assay to probe correlations between nanoparticle-mediated uptake, endosomal escape frequency, and mRNA translation.
Michael J. Munson +8 more
doaj +1 more source
Endosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design. [PDF]
The rise of biologics and RNA-based therapies challenges the limitations of traditional drug treatments. However, these potent new classes of therapeutics require effective delivery systems to reach their full potential.
Hagedorn L +3 more
europepmc +2 more sources
Accelerated Endosomal Escape of Splice-Switching Oligonucleotides Enables Efficient Hepatic Splice Correction. [PDF]
Weiss S +24 more
europepmc +2 more sources
The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. [PDF]
Encapsulation of drugs within nanocarriers that selectively target malignant cells promises to mitigate side effects of conventional chemotherapy and to enable delivery of the unique drug combinations needed for personalized medicine.
Ashley, Carlee E +20 more
core +10 more sources
Endosomal escape in cell-penetrating peptide (CPP)-based drug/macromolecule delivery systems is frequently insufficient. The CPP-fused molecules tend to remain trapped inside endosomes and end up being degraded rather than delivered into the cytosol. One
Tet Htut Soe +2 more
doaj +1 more source
Novel endosomolytic compounds enable highly potent delivery of antisense oligonucleotides
Two new endosomolytic small compounds increase delivery of splice-switching oligonucleotides by interfering with their trafficking to the LAMP1-positive endosomal compartments, inducing endosomal membrane rupture and concurrent oligonucleotide escape ...
Jeremy P. Bost +20 more
doaj +1 more source
Rapid phagosomal escape mediated by listeriolysin O (LLO) is a prerequisite for Listeria monocytogenes intracellular replication and pathogenesis. Escape takes place within minutes after internalization from vacuoles that are negative to the early ...
Robert J. Cain +3 more
doaj +1 more source
An Endosomal Escape Trojan Horse Platform to Improve Cytosolic Delivery of Nucleic Acids. [PDF]
Endocytosis is a major bottleneck toward cytosolic delivery of nucleic acids, as the vast majority of nucleic acid drugs remain trapped within endosomes.
Narum S +5 more
europepmc +2 more sources

